7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells.

      Prostaglandins & other lipid mediators
      Angiogenesis Inducing Agents, antagonists & inhibitors, Angiogenesis Inhibitors, pharmacology, Cell Movement, drug effects, Cell Proliferation, Cells, Cultured, Dose-Response Relationship, Drug, Down-Regulation, Endothelial Cells, cytology, metabolism, Endothelium, Vascular, Extracellular Signal-Regulated MAP Kinases, Humans, Morphogenesis, Prostaglandin D2, analogs & derivatives, Proto-Oncogene Proteins c-myc, RNA, Messenger, Receptors, Vascular Endothelial Growth Factor, Recombinant Proteins, genetics, Time Factors, Transcription Factors, Umbilical Veins, Vascular Endothelial Growth Factor A

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) upregulates expression of vascular endothelial growth factor (VEGF), but may inhibit angiogenesis. We found that 15d-PGJ(2) (1-10muM) attenuated all VEGF-induced angiogenic activities in human umbilical vein endothelial cells (HUVEC). It blocked almost completely cell proliferation, potently reduced migration, assembly into tube-like network on matrigel, and growth of capillaries into collagen gel. 15d-PGJ(2) inhibited expression of VEGFR-1 and VEGFR-2 receptors both at mRNA and protein levels. This inhibition, however, was transient (observed after 6-12h, but not after 24h) and weak (20-30%), and could not fully explain inhibition of response to VEGF. Accordingly, proliferation was inhibited when 15d-PGJ(2) was added 24h after VEGF or in cells stimulated with basic fibroblast growth factor. Interestingly, 15d-PGJ(2) decreased activities of c-jun and c-myc in HUVEC and overexpression of c-myc attenuated its antiproliferative effects. This suggests that inhibition of this transcription factor by 15d-PGJ(2) contributes to decrease in angiogenic response.

          Related collections

          Author and article information

          Comments

          Comment on this article